China, Oct. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Modulatory Effect of Genetic Susceptibility to Depression on iTBS-Induced Neuroplasticity: A Dual-Module Investigation in Healthy Individuals and Patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134890
Registration Time: 2026/10/21
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of University of Science and Technology of China
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348774
Published by HT Digital Content Services with permission from Health Daily Digest....